title: Timing of Ibuprofen Use and Musculoskeletal Adaptations to Exercise Training in Older Adults.
abstract: Prostaglandins (PG) increase in bone in response to mechanical loading and stimulate bone formation. Inhibition of cyclooxygenase (COX), the enzyme responsible for PG synthesis, by non-steroidal anti-inflammatory drugs (NSAIDs) impairs the bone formation response to loading in animals when administered before, but not after, loading. The aim was to determine whether the timing of ibuprofen use (400 mg before versus after exercise sessions) is a significant determinant of the adaptive response of BMD to exercise training in older adults. We hypothesized that taking ibuprofen before exercise would attenuate the improvements in total hip and lumbar spine BMD in response to 36 weeks of training when compared with placebo or with ibuprofen use after exercise. Untrained women and men (N=189) aged 60 to 75 years were randomly assigned to 1 of 3 treatment arms: placebo before and after exercise (PP); ibuprofen before and placebo after exercise (IP); and placebo before and ibuprofen after exercise (PI). The difference between groups in the change in BMD was not significant when IP was compared with either PP (hip, -0.5% (-1.4, 0.4); spine, 0.1% (-0.9, 1.2)) or PI (hip, 0.3% (-0.6, 1.2); spine, 0.5% (-0.5, 1.5)). Ibuprofen use appeared to have more adverse effects on BMD in women than men. The study demonstrated that ibuprofen use did not significantly alter the BMD adaptations to exercise in older adults, but this finding should be interpreted cautiously. It had been expected that the inhibition of bone formation by ibuprofen would be as robust in men than women, but this did not appear to be the case and may have limited the power to detect the effects of ibuprofen. Further research is needed to understand whether NSAID use counteracts, in part, the beneficial effects of exercise on bone.
authors: College of Nursing, University of Colorado ; Department of Medicine, Division of Geriatric Medicine, University of Colorado.
authors: Catherine M
authors: CM
authors: Jankowski
authors: Department of Medicine, Division of Geriatric Medicine, University of Colorado.
authors: Karen
authors: K
authors: Shea
authors: Department of Medicine, General Internal Medicine, University of Colorado.
authors: Daniel W
authors: DW
authors: Barry
authors: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado.
authors: Sunny A
authors: SA
authors: Linnebur
authors: Department of Preventive Medicine and Biometrics, University of Colorado.
authors: Pamela
authors: P
authors: Wolfe
authors: Department of Preventive Medicine and Biometrics, University of Colorado.
authors: John
authors: J
authors: Kittelson
authors: Department of Medicine, Division of Geriatric Medicine, University of Colorado.
authors: Robert S
authors: RS
authors: Schwartz
authors: Department of Medicine, Division of Geriatric Medicine, University of Colorado.
authors: Wendy M
authors: WM
authors: Kohrt
keywords: Exercise training; bone mineral density; cyclooxygenase; nonsteroidal anti-inflammatory drugs; prostaglandins
references: Am J Physiol Endocrinol Metab. 2002 Mar;282(3):E551-6
references: 11832356
references: J Bone Miner Res. 1996 Nov;11(11):1688-93
references: 8915776
references: J Clin Invest. 1996 Dec 1;98(11):2446-9
references: 8958205
references: J Bone Miner Res. 2010 Jun;25(6):1415-22
references: 20200939
references: Am J Physiol. 1994 Aug;267(2 Pt 1):E287-92
references: 8074209
references: J Bone Miner Res. 2003 Oct;18(10):1795-802
references: 14584890
references: Trends Endocrinol Metab. 2010 May;21(5):294-301
references: 20079660
references: J Bone Miner Res. 1998 Dec;13(12):1924-31
references: 9844111
references: Osteoporos Int. 2013 Jan;24(1):383-8
references: 22349912
references: J Bone Miner Res. 1998 Jun;13(6):1039-44
references: 9626636
references: Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):43-50
references: 23723142
references: Clin J Sport Med. 2013 Jul;23(4):283-6
references: 23528841
references: Connect Tissue Res. 2004;45(1):40-9
references: 15203939
references: J Clin Endocrinol Metab. 2006 Aug;91(8):2986-93
references: 16735495
references: Nat Rev Drug Discov. 2012 Mar 01;11(3):234-50
references: 22378270
references: J Appl Physiol (1985). 2007 Aug;103(2):693-9
references: 17303714
references: Am J Physiol Regul Integr Comp Physiol. 2011 Mar;300(3):R655-62
references: 21160058
references: J Bone Miner Res. 1996 Jan;11(1):29-35
references: 8770694
references: Clin Pharmacokinet. 1998 Feb;34(2):101-54
references: 9515184
references: J Clin Endocrinol Metab. 2001 Oct;86(10):5067-70
references: 11600586
references: Osteoporos Int. 2006;17(9):1410-9
references: 16791706
references: Exerc Sport Sci Rev. 2000 Oct;28(4):185-8
references: 11064853
references: Br J Sports Med. 2011 Feb;45(2):85-90
references: 19666628
references: J Bone Miner Res. 2005 Mar;20(3):438-46
references: 15746988
references: J Adolesc Health. 2002 Mar;30(3):150-3
references: 11869920
references: Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):85-94
references: 17164136
references: Calcif Tissue Int. 2002 Apr;70(4):320-9
references: 12004337
references: Arthritis Rheum. 2011 Jan;63(1):137-47
references: 20882669
references: J Bone Miner Res. 1997 Sep;12(9):1424-30
references: 9286758
references: J Bone Miner Res. 1997 May;12(5):769-77
references: 9144343
references: Osteoporos Int. 2012 Apr;23(4):1255-65
references: 21710339
references: Arthritis Rheum. 2013 Jun;65(6):1569-78
references: 23436303
references: J Biol Chem. 1982 Feb 25;257(4):1632-8
references: 6799511